Home
Browse All Titles
Sign In
Browse All Titles
Pharmacy Practice and the Law
About
Table of Contents
Main Index
Case Studies
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com
◀
*
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
Y
Z
▶
View All
DailyMed
Daniel Family Pharmacy (1999)
Daniel Family Pharmacy
Dispensing of Schedule III, IV, and V Controlled Substances
DATA
debit cards, use of
Deficit Reduction Act
Delaney Clause
De Modena v. Kaiser Foundation Health Plan, Inc. (1984)
de novo
Department of Health and Human Services (DHHS)
Health Insurance Portability and Accountability Act of 1996
multiple-source drugs
Penalties and Enforcement
scheduling authority
Food and Drug Administration, overview
laws made by
pedigrees
reimportation of drugs
Use and Disclosure of PHI; Right to Access
Department of Homeland Security Appropriations Act of 2007
deposition, purposes for
See Drug Efficacy Study Implementation (DESI)
Marketed Unapproved Drugs
Over-the-Counter Drug Review
United States v. Hiland
Drug Efficacy Study Implementation
New Drug Approval
See Drug Efficacy Study Implementation (DESI)
devices
adulteration regulations
FDA definitions, overview
prohibited acts, penalties, and enforcement, FDCA
Defining and Distinguishing Drugs from Foods, Dietary Supplements, Devices, and Cosmetics
federal regulations, overview
vs. drugs, FDA regulations
device-user facility
Dietary Supplement and Nonprescription Drug Consumer Protection Act (2006)
Dietary Supplement Health and Education Act of 1994 (DSHEA)
Dietary Supplements vs Drugs
criticisms of
for pharmacists, implications of
Medical Device User Fee and Modernization Act of 2002
damages, malpractice
DEA
DeCordova v. State of Colorado (1994)
de-identification of PHI
Delaware, Inc. v. Venice Hospital
demonstration projects, OBRA ‘90
dependence, defined
detoxification treatment, defined
DHHS
dietary supplements
Defining and Distinguishing Drugs from Foods, Dietary Supplements, Devices, and Cosmetics
labeling
vs. drugs, FDA regulations
containing drugs
FDA definitions, overview
united states V. hiland (1990) - United States V. Hiland
directions for use
misbranding, overview
State Regulation of Third-Party Plans
direct supervision and control
disciplinary actions
continuous quality improvement programs
in the matter of sobel V. board of pharmacy (1994) - in the Matter of CVS Pharmacy Wayne
schram V. department of professional regulation (1992) - Schram V. Department of Professional Regulation
impaired pharmacist programs
overview of
discovery rule
Refresh
first
prev
1
2
3
30
select
next
last
Displaying items 1 - 30 of 79